The study evaluates the feasibility and safety of the Endoscopic Nipple Sparing Mastectomy (E-NSM) technique for women at high risk of breast cancer, focusing on performing the surgery with minimal incisions and immediate reconstruction.
A total of 10 patients underwent the procedure with a complete success rate, showing only a small percentage of complications, primarily minor issues like skin necrosis and hematomas.
Patients reported high satisfaction with the esthetic results, leading to a recommendation for the technique; however, further research involving a larger patient group is needed for validation.
A study analyzed the relationship between the volume of ovarian cancer surgeries at hospitals in France and patient outcomes, focusing on data from 2012 to 2016.
It included 8429 patients and found that those treated in hospitals performing at least 20 surgeries per year had better 5-year overall survival (OS) rates compared to those in lower-volume hospitals.
The findings indicate that high-volume hospitals (≥ 20 cases/year) are linked to improved patient outcomes, particularly when compared to hospitals performing fewer than 10 surgeries per year, highlighting the importance of surgical experience in treating ovarian cancer.
A personalized 3D breast model could enhance patient-surgeon discussions and surgical planning by accurately simulating breast tissue properties.
The study aimed to measure breast skin thickness and the stiffness of different breast tissues, considering factors like age, BMI, and menopausal status as potential influences.
Results indicated that menopausal status significantly impacted breast skin thickness and stiffness, with average measurements found to be 1.83 mm for skin thickness and 39 kPa for breast tissue stiffness, and future work will focus on integrating these findings into a biomechanical model.
This study investigates the effects of whole-body cryotherapy (WBC) on joint pain caused by aromatase inhibitors in breast cancer patients, aiming to determine if WBC can alleviate pain better than a placebo treatment.*
-
It is a randomized, double-blind, placebo-controlled clinical trial with 56 participants experiencing significant joint pain, measuring outcomes like pain severity and quality of life at various time points post-treatment.*
-
Ethics approval has been secured, and the findings will be shared in a peer-reviewed journal and at international conferences to inform future treatment approaches.*